Pilot Investigation of Stem Cells in Stroke Phase II Efficacy "PISCES-II"


Phase 2 Results N/A

Summary of Purpose

The primary aim of this Phase II trial is to determine whether it is sufficiently likely that CTX DP treatment at a dose level of 20 million cells improves the recovery in the use of the paretic arm in acute stroke patients to justify a subsequent larger prospectively controlled study. This study will evaluate the safety and efficacy of intracerebral CTX DP at a dose level of 20 million cells in patients...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 1 December 2017.

1 Jun 2014 16 Apr 2014 16 Aug 2017 16 Aug 2017 1 Dec 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics


Conditions See All


Trial Design

  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Single Group Assignment


Not available